Selection of insulinoma cell lines with resistance to interleukin-1β- and γ-interferon-induced cytotoxicity

Diabetes

Volumn 49, Issue 4, 2000, Pages 562-570

  Chen, Guoxun ^a   Hohmeier, Hans E ^b   Gasa, Rosa ^a   Tran, Veronique Vien ^a   Newgard, Christopher B ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BetaGene Inc   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SELECTION; CELL TRANSPLANTATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE TRANSLOCATION; GENETIC TRANSFECTION; INCUBATION TIME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PLASMID; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 0034070569     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.4.562     Document Type: Article

References (22)

1. Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Ann Rev Immunol 12:735-773, 1994
2. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
3. Rabinovitch A: Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1:215-240, 1993
4. Corbett JA, McDaniel ML: Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903, 1992
5. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
6. Newgard CB, Clark S, BeltrandelRio H, Hohmeier HE, Quaade C, Normington K: Engineered cell lines for insulin replacement in diabetes: current status and future prospects. Diabetologia 40 (Suppl. 2):S42-S47, 1997
7. Newgard CB, Clark S, Thigpen A, Hohmeier HE, Quaade C, Tran VV, Normington K: Engineering of cell lines for insulin replacement in IDDM. Can J Diabetes Care 23:52-58, 1999
8. Efrat S, Fleischer N: Engineering the pancreatic β-cell. In Diabetes Mellitus: A Fundamental and Clincial Text. LeRoith D, Taylor SI, Olefsky JM, Eds. New York, Lippincott-Raven, 1996, p. 438-442
9. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998
10. Borg LA, Cagliero E, Sandler S, Welsh N, Eizirik DL: Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology 130:2851-2857, 1992
11. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB: Establishment of 2-mercaptoethanol dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178, 1992
12. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424-430, 2000
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
14. Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333, 1994
15. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB: Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion: a re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:16146-16154, 1998
16. Dignam JD, Martin PL, Shastry BS, Roeder RG: Eurcaryotic gene transcription with purified components. Methods Enzymol 101:582-598, 1983
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
18. Dinarello CA: Interleukin-1. In The Cytokine Handbook. Third ed. Thomson AW, Ed. New York, Academic Press, 1998, p. 35-72
19. O'Neill LAJ, Greene C: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657, 1998
20. Gasa R, Tran VV, Eizirik D, Newgard CB: The mechanism by which MnSOD expression blocks IL-1β-induced cytotoxicity and iNOS expression in INS-1 cells (Abstract). Diabetes 48 (Suppl. 1):A234, 1999
21. De Maeyer E, De Maeyer-Guignard J: Interferons. In The Cytokine Handbook. Third ed. Thomson AW, Ed. New York, Academic Press, 1998, p. 491-516
22. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-γ. Ann Rev Immunol 15:749-795, 1997